|
Site Search
|
SurExam Has China Rights to New Ovarian Cancer Test
publication date: Feb 14, 2008
SurExam Life Science & Technology (Shenzhen) Co. has been granted the right to develop a test for early stage ovarian cancer in China that was discovered at Yale School of Medicine. Dr. Jiasen Xu, chief executive officer of SurExam, is a graduate of Yale. The new test uses proteins that the body produces in response to a tumor, along with the tumor proteins, which gives the test the ability to detect both early- and late-stage ovarian cancer with a 99% accuracy. More details...
|
Partner Events
September 16-18, 2008
San Francisco, CA
October 11-13, 2008
Dalian, China
November 9-11, 2008
Shanghai, China
>> More details...
|